DAPA-CKD: The Beginning of a New Era in Renal Protection

por Cherney, David Z.I., Verma, Subodh
Publicado 2021

Evolution of Renal Hyperfiltration and Arterial Stiffness From Adolescence Into Early Adulthood in Type 1 Diabetes

por Cherney, David Z.I., Sochett, Etienne B.
Publicado 2011

Response to Comment on: Cherney and Sochett. Evolution of Renal Hyperfiltration and Arterial Stiffness From Adolescence Into Early Adulthood in Type 1 Diabetes. Diabetes Care 2011;...

por Cherney, David Z.I., Sochett, Etienne B.
Publicado 2011

Sex Differences in Renal Responses to Hyperglycemia, l-Arginine, and l-NMMA in Humans With Uncomplicated Type 1 Diabetes

por Cherney, David Z.I., Scholey, James W., Sochett, Etienne B.
Publicado 2013

Preventing CKD in Developed Countries

por Luyckx, Valerie A., Cherney, David Z.I., Bello, Aminu K.
Publicado 2019

Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations

por Yau, Kevin, Dharia, Atit, Alrowiyti, Ibrahim, Cherney, David Z.I.
Publicado 2022

Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations

por Yau, Kevin, Dharia, Atit, Alrowiyti, Ibrahim, Cherney, David Z.I.
Publicado 2022

Cardiorenal Protection in Diabetic Kidney Disease

por Lee, Jason F., Berzan, Ecaterina, Sridhar, Vikas S., Odutayo, Ayodele, Cherney, David Z.I.
Publicado 2021

The Acute Effect of Clamped Hyperglycemia on the Urinary Excretion of Inflammatory Cytokines/Chemokines in Uncomplicated Type 1 Diabetes: A pilot study

por Cherney, David Z.I., Scholey, James W., Sochett, Etienne, Bradley, Timothy J., Reich, Heather N.
Publicado 2011

Effect of Direct Renin Inhibition on Renal Hemodynamic Function, Arterial Stiffness, and Endothelial Function in Humans With Uncomplicated Type 1 Diabetes: A pilot study

por Cherney, David Z.I., Lai, Vesta, Scholey, James W., Miller, Judith A., Zinman, Bernard, Reich, Heather N.
Publicado 2010

The Effect of Direct Renin Inhibition Alone and in Combination With ACE Inhibition on Endothelial Function, Arterial Stiffness, and Renal Function in Type 1 Diabetes

por Cherney, David Z.I., Scholey, James W., Jiang, Shan, Har, Ronnie, Lai, Vesta, Sochett, Etienne B., Reich, Heather N.
Publicado 2012

Hemoglobin A1c Reduction With the GLP-1 Receptor Agonist Semaglutide Is Independent of Baseline eGFR: post hoc Analysis of the SUSTAIN and PIONEER Programs

por Cherney, David Z.I., Hadjadj, Samy, Lawson, Jack, Mosenzon, Ofri, Tuttle, Katherine, Vrhnjak, Blaz, Rasmussen, Søren, Bain, Stephen C.
Publicado 2022

The Effects of Sotagliflozin in Type 1 Diabetes on Clinical Markers Associated With Cardiorenal Protection: An Exploratory Analysis of inTandem3

por Sridhar, Vikas S., Heerspink, Hiddo J.L., Davies, Michael J., Banks, Phillip, Girard, Manon, Garg, Satish K., Cherney, David Z.I.
Publicado 2023

Renal Hyperfiltration and Arterial Stiffness in Humans With Uncomplicated Type 1 Diabetes

por Cherney, David Z.I., Sochett, Etienne B., Lai, Vesta, Dekker, Maria G., Slorach, Cameron, Scholey, James W., Bradley, Timothy J.
Publicado 2010

Renal and Vascular Effects of Combined SGLT2 and Angiotensin-Converting Enzyme Inhibition

por Lytvyn, Yuliya, Kimura, Karen, Peter, Nuala, Lai, Vesta, Tse, Josephine, Cham, Leslie, Perkins, Bruce A., Soleymanlou, Nima, Cherney, David Z.I.
Publicado 2022

Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes

por Bjornstad, Petter, Laffel, Lori, Tamborlane, William V., Simons, Gudrun, Hantel, Stefan, von Eynatten, Maximilian, George, Jyothis, Marquard, Jan, Cherney, David Z.I.
Publicado 2018

Markers of Kidney Injury, Inflammation, and Fibrosis Associated With Ertugliflozin in Patients With CKD and Diabetes

por Liu, Hongyan, Sridhar, Vikas S., Lovblom, Leif Erik, Lytvyn, Yuliya, Burger, Dylan, Burns, Kevin, Brinc, Davor, Lawler, Patrick R., Cherney, David Z.I.
Publicado 2021

Heart and Kidney Outcomes With Ertugliflozin in People with Non-albuminuric Diabetic Kidney Disease: A post hoc Analysis from the Randomized VERTIS CV Trial

por Cherney, David Z.I., Dagogo-Jack, Samuel, Cosentino, Francesco, Pratley, Richard E., Frederich, Robert, Maldonado, Mario, Liu, Chih-Chin, Cannon, Christopher P.
Publicado 2022

The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus

por Cherney, David ZI, Perkins, Bruce A, Soleymanlou, Nima, Har, Ronnie, Fagan, Nora, Johansen, Odd Erik, Woerle, Hans-Juergen, von Eynatten, Maximilian, Broedl, Uli C
Publicado 2014

Effect of Protein Kinase Cβ Inhibition on Renal Hemodynamic Function and Urinary Biomarkers in Humans With Type 1 Diabetes: A Pilot Study

por Cherney, David Z.I., Konvalinka, Ana, Zinman, Bernard, Diamandis, Eleftherios P., Soosaipillai, Anton, Reich, Heather, Lorraine, Joanne, Lai, Vesta, Scholey, James W., Miller, Judith A.
Publicado 2009